Dr. Michael Lauzardo is chief of the Division of Infectious Diseases and Global Medicine in the College of Medicine. His research focuses on latent tuberculosis treatment, molecular epidemiology of tuberculosis and tuberculosis in at-risk populations. He also oversees tuberculosis research at UF's Haiti research lab in Gressier.
Areas of Expertise (4)
A multi-faceted approach to COVID-19 surveillance at a large university campus in the southeastern USDisaster Medicine and Public Health Preparedness
Emily M. Klann, et al.
The coronavirus disease 2019 (COVID-19) pandemic continues to present unique public health challenges both within the United States and across the globe. Institutions of higher learning are tasked with preventing and responding to COVID-19 on campus while also considering implications for the surrounding communities.
Low-frequency variants in mildly symptomatic vaccine breakthrough infections presents a doubled-edged swordJournal of Medical Virology
Brittany R. Magalis, et al.
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOC) has raised questions regarding vaccine protection against SARS-CoV-2 infection, transmission, and ongoing virus evolution. Twenty-three mildly symptomatic “vaccination breakthrough” infections were identified as early as January 2021 in Alachua County, Florida, among individuals fully vaccinated with either the BNT162b2 (Pfizer) or the Ad26 (Janssen/J&J) vaccines.
Applying Lean principles to create a high throughput mass COVID-19 vaccination siteBMJ Open Quality
Meghan N. Froman, et al.
A high throughput COVID-19 vaccination site was created using Lean principles and tools. Mass-vaccination sites can achieve high output by creating a standard physical design for workspaces and standardised work protocols, and by timing each step in the vaccination process to create a value stream map that can identify and remove all wasteful steps.